HBOT for Multiple Sclerosis: Slowing Progression Naturally

For the 200,000+ Indians living with Multiple Sclerosis, daily life means managing a complex autoimmune condition that attacks the nervous system. While there's no cure, HBOT offers a complementary approach with growing evidence behind it.

Understanding Multiple Sclerosis

MS is an autoimmune disease where the immune system attacks the myelin sheath protecting nerves in the brain and spinal cord. Symptoms include fatigue, mobility issues, vision problems, cognitive changes, and bladder dysfunction. The disease typically follows relapsing-remitting or progressive patterns.

The HBOT Rationale

HBOT addresses several pathological features of MS:

• Reduces neuroinflammation
• Improves cerebral blood flow
• Supports myelin repair (remyelination)
• Modulates immune system overactivity
• Mobilizes stem cells
• Improves mitochondrial function

Clinical Evidence

HBOT for MS has been studied since the 1980s with mixed results. The most rigorous recent reviews suggest:

• Modest improvements in fatigue (a major MS symptom)
• Reduced bladder dysfunction in some patients
• Improved walking ability in select cases
• Potential reduction in relapse frequency (anecdotal)

"HBOT is not a cure for MS, but for many of my patients it's part of a comprehensive strategy that has dramatically improved their quality of life." — Neurologist quote

Symptoms That May Improve

MS patients undergoing HBOT most commonly report improvements in:

• Fatigue (the most common and disabling symptom)
• Bladder control
• Spasticity and muscle stiffness
• Walking ability and balance
• Cognitive function ('MS brain fog')
• Sleep quality
• Overall energy and mood

HBOT Protocol for MS

Standard MS protocols use:

• Pressure: 1.5–2.0 ATA (lower than infection protocols)
• Duration: 60–90 minutes
• Loading phase: 20 sessions over 4 weeks
• Maintenance phase: 1–2 sessions per month indefinitely

The maintenance phase is unique to chronic conditions like MS — many patients report symptom worsening if they discontinue completely.

Combining with Conventional Treatment

HBOT does not replace disease-modifying therapies (DMTs) for MS. Standard MS treatments — interferons, glatiramer acetate, monoclonal antibodies — remain first-line. HBOT works alongside these therapies, addressing symptoms and quality of life. Always coordinate with your neurologist.

Realistic Expectations

MS is a complex disease and individual responses vary widely. Some patients report dramatic improvements; others see modest gains. The most consistent improvement is in fatigue. Set realistic expectations: HBOT is part of a comprehensive MS management plan, not a magic cure.

HBOTRx partners with experienced centers offering MS protocols. Contact us for a free consultation to discuss whether HBOT might fit into your MS care plan.